These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9165637)

  • 1. Longitudinal courses of thought disorder in schizophrenia and schizoaffective disorder.
    Marengo JT; Harrow M
    Schizophr Bull; 1997; 23(2):273-85. PubMed ID: 9165637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thought disorder. A function of schizophrenia, mania, or psychosis?
    Marengo J; Harrow M
    J Nerv Ment Dis; 1985 Jan; 173(1):35-41. PubMed ID: 3965610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder.
    Reichenberg A; Weiser M; Rabinowitz J; Caspi A; Schmeidler J; Mark M; Kaplan Z; Davidson M
    Am J Psychiatry; 2002 Dec; 159(12):2027-35. PubMed ID: 12450952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty year multi-follow-up of different types of hallucinations in schizophrenia, schizoaffective disorder, bipolar disorder, and depression.
    Goghari VM; Harrow M
    Schizophr Res; 2016 Oct; 176(2-3):371-377. PubMed ID: 27349816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorder.
    Gotra MY; Hill SK; Gershon ES; Tamminga CA; Ivleva EI; Pearlson GD; Keshavan MS; Clementz BA; McDowell JE; Buckley PF; Sweeney JA; Keedy SK
    Schizophr Res; 2020 Sep; 223():148-157. PubMed ID: 32674921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 20-year multi-follow-up of hallucinations in schizophrenia, other psychotic, and mood disorders.
    Goghari VM; Harrow M; Grossman LS; Rosen C
    Psychol Med; 2013 Jun; 43(6):1151-60. PubMed ID: 23034091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The early course of schizophrenic thought disorder.
    Harrow M; Marengo J; McDonald C
    Schizophr Bull; 1986; 12(2):208-24. PubMed ID: 3715415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive function in schizoaffective disorder and clinical subtypes of schizophrenia.
    Goldstein G; Shemansky WJ; Allen DN
    Arch Clin Neuropsychol; 2005 Mar; 20(2):153-9. PubMed ID: 15708725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight and symptom change in schizophrenia and other disorders.
    Weiler MA; Fleisher MH; McArthur-Campbell D
    Schizophr Res; 2000 Sep; 45(1-2):29-36. PubMed ID: 10978870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schizoaffective disorder: a form of schizophrenia or affective disorder?
    Evans JD; Heaton RK; Paulsen JS; McAdams LA; Heaton SC; Jeste DV
    J Clin Psychiatry; 1999 Dec; 60(12):874-82. PubMed ID: 10665641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive functioning and insight in schizophrenia and in schizoaffective disorder.
    Birindelli N; Montemagni C; Crivelli B; Bava I; Mancini I; Rocca P
    Riv Psichiatr; 2014; 49(2):77-83. PubMed ID: 24770573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of schizoaffective disorder. Are there any differences with respect to schizophrenia?
    Pinna F; Sanna L; Perra V; Pisu Randaccio R; Diana E; Carpiniello B;
    Riv Psichiatr; 2014; 49(1):41-9. PubMed ID: 24572583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychopathological and demographic characteristics of hallucinating patients with schizophrenia and schizoaffective disorder: an analysis based on AMDP data.
    Baethge C; Jänner M; Gaebel W; Malevani J
    Eur Arch Psychiatry Clin Neurosci; 2017 Jun; 267(4):295-301. PubMed ID: 27752826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia.
    Correll CU; Smith CW; Auther AM; McLaughlin D; Shah M; Foley C; Olsen R; Lencz T; Kane JM; Cornblatt BA
    J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):475-90. PubMed ID: 18928412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series?
    Craig TJ; Bromet EJ; Fennig S; Tanenberg-Karant M; Lavelle J; Galambos N
    Am J Psychiatry; 2000 Jan; 157(1):60-6. PubMed ID: 10618014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the borders of the schizoaffective spectrum: a categorical and dimensional approach.
    Peralta V; Cuesta MJ
    J Affect Disord; 2008 May; 108(1-2):71-86. PubMed ID: 18029027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring cognitive insight in middle-aged and older patients with psychotic disorders.
    Pedrelli P; McQuaid JR; Granholm E; Patterson TL; McClure F; Beck AT; Jeste DV
    Schizophr Res; 2004 Dec; 71(2-3):297-305. PubMed ID: 15474900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential impairment of social cognition factors in bipolar disorder with and without psychotic features and schizophrenia.
    Thaler NS; Allen DN; Sutton GP; Vertinski M; Ringdahl EN
    J Psychiatr Res; 2013 Dec; 47(12):2004-10. PubMed ID: 24112946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression during the longitudinal course of schizophrenia.
    Sands JR; Harrow M
    Schizophr Bull; 1999; 25(1):157-71. PubMed ID: 10098919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of work outcome in schizophrenia and schizoaffective disorder: role of cognitive function.
    Kaneda Y; Jayathilak K; Meltzer HY
    Psychiatry Res; 2009 Sep; 169(2):178-9. PubMed ID: 19646764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.